J&J awarded $18m in fake surgical devices case

Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Intuitive resolves robotic surgery dispute with J&J unit

10 August 2023 Dispute centred on alleged infringement of several patents related to keyhole surgery | Big pharma company acquired defendant firm in $3.4bn deal four years ago.

Americas

J&J agrees Stelara deals with generics

14 June 2023 Deal thought to be aimed at helping pharma giant attain sales target as patents start to expire | Israeli drugmaker will join with Icelandic firm to unveil a copycat version of blockbuster treatment by 2025.

Big Pharma

J&J settles Amgen clash over blockbuster psoriasis drug

25 May 2023 Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents.

More on this story

Medtech

Intuitive resolves robotic surgery dispute with J&J unit

10 August 2023 Dispute centred on alleged infringement of several patents related to keyhole surgery | Big pharma company acquired defendant firm in $3.4bn deal four years ago.

Americas

J&J agrees Stelara deals with generics

Big Pharma

J&J settles Amgen clash over blockbuster psoriasis drug

25 May 2023 Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents.

More on this story

Medtech

Intuitive resolves robotic surgery dispute with J&J unit

10 August 2023 Dispute centred on alleged infringement of several patents related to keyhole surgery | Big pharma company acquired defendant firm in $3.4bn deal four years ago.

Americas

J&J agrees Stelara deals with generics

Big Pharma

J&J settles Amgen clash over blockbuster psoriasis drug

25 May 2023 Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents.